Medicine Information

Celebrex? Vioxx? Can My Doctor Provide Me With Safe Prescription Painkillers?


The news has been full of the recent FDA findings on a new set of drugs to help relieve pain. These drugs have been approved for re-release, but it is unclear whether Vioxx will be available again and whether physicians will feel comfortable prescribing Celebrex and Bextra for many of their patients.

What happened to Celebrex and Vioxx?

Celebrex, Vioxx, and Bextra are all non-steroidal anti-inflammatory drugs (NSAIDs, pronounced en-said-z), similar to drugs like ibuprofen and naproxen, that are available over the counter (OTC). Celebrex, Vioxx and Bextra, (sometimes called Cox-2 inhibitors) however, use a slightly different method to achieve the same effect as their OTC cousins; this new method was supposed to limit the side effects some people experience on OTC drugs, including stomach and intestinal problems and allergic reactions. It was thought that because these drugs were less likely to cause such problems, they might be safer for patients with painful chronic conditions (like arthritis) to use for long periods of time.

Unfortunately, some studies of Cox-2 inhibitors suggest that while they don't cause the sorts of side effects of other NSAIDs, they may create a greater risk of myocardial infarction (heart attack) or stroke. For people already at risk for these diseases (including those who have already experienced a stroke or heart problem), taking these drugs over the long run may significantly increase the risk of heart problems.

Now What Can I Do To Get Pain Relief?

Until a final decision has been made on each of these drugs, what can your healthcare provider do to help you with pain management? Here are important pieces of information to think about in determining what next steps to take:

* The Cox-2 inhibitors were not shown to be more effective than other NSAIDs, like naproxen. If you've been on or thinking about trying Vioxx or another Cox-2 inhibitor, you may be able to use an older anti-inflammatory drug. Naproxen, one of the older NSAIDs, may be an anti-inflammatory drug that actually lowers heart attack risk.

* Some people started on a Cox-2 inhibitors because they had a stomach ulcer or other risk factors for stomach or intestine bleeding (for example, people on blood thinners), which may be made worse by older anti-inflammatory drugs. For some people who are at risk for bleeding, other options like acetaminophen may be an option.

* There are lots of other medical options. Steroids can be used for shorter periods of time to manage inflammatory pain from diseases like arthritis and lupus. Opioids (drugs that resemble opium), such as oxycodone, codeine, and hydrocodone (Vicodin) can help with pain management, but they can have serious side effects, and some of them can be addictive, so working closely with your healthcare worker is key to determine if these will work for you. In addition, some antidepressants may help with chronic (long-term) pain, though the way this works isn't yet known

* New procedures may be of assistance to you. Nerve block therapy (in which certain nerves are temporarily anaesthetized) can relieve pain temporarily. "Implantable "technologies, like spinal cord stimulation (SCS) systems and implantable drug delivery systems, do seem to help some people for whom other pain relief methods don't work.

* If you aren't getting the relief you need (with or without the use of Cox-2 inhibitors), you may want to consult a pain specialist. Some large hospitals (such as Stanford University) have departments devoted to pain management. The American Board of Pain Medicine and the PainConnection (at painconnection.org) can help you locate a pain specialist who can work with your other healthcare professionals to put a new treatment plan together for you.

Harris, G., "F.D.A. Official Admits 'Lapses' on Vioxx," New York Times, March 2, 2005

Krames, E., "Implantable Technologies: Spinal Cord Stimulation and Implantable Drug Delivery Systems," http://www.painconnection.org/

Winfield, J. et al "A Primer on Pain Management: Optimal Therapy for the Patient in Pain," Medscape CME, February 2005.

Copyright (C) Shoppe.MD and Ian Mason, 2004-2005

Ian Mason, owner of Shoppe.MD, your source for Online Prescription Medications, drug information and support forums.

Ian is a fat-to-fit student of health, weight loss, exercise, and several martial arts; maintaining several websites in an effort to help provide up-to-date and helpful information for other who share his interests in health of body and mind.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Salt Lake Tribune

Commentary: The Tribune was wrong. Medicine often involves a risk to the patient.
Salt Lake Tribune
(Courtesy of the Utah Department of Health) A health department initiative called Talk to Your Pharmacist placed stickers on bottles to prompt prescribers to talk to their pharmacist about the risk of using opioids. By Lynn Webster | For The Tribune ...



The Guardian

Adam Kay: 'If I had kids I would put them off studying medicine'
The Guardian
Kay had enjoyed a longstanding interest in comedy, performing in medical student revues, and later in corporate gigs for pharmaceutical companies. He'd also been on Radio 4 and performed at the Edinburgh festival, so comedy was the obvious way to go ...



Florida Flambeau

FSU College of Medicine hosts World AIDS Day vigil
Florida Flambeau
From 2008 to 2010, there were about 32 new HIV cases and 19 new AIDS cases in Leon County. During this time period, Leon County reported 1,392 cases of gonorrhea, chlamydia and syphilis. Gonorrhea and syphilis rates are higher in this county than ...

and more »


The Hindu

'Exciting careers beyond engineering and medicine'
The Hindu
In a State where a huge chunk of student population go towards engineering and medicine, choosing a course other than the two requires a certain aptitude. It's the aptitude that matters when choosing a career, experts from various fields advised ...



KFSN-TV

New Treatment for Neuropathy: Medicine's Next Big Thing?
KFSN-TV
Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs. (KFSN). KFSN. By Margot Kim. Saturday, December 09, 2017 11:48PM. Thirty percent of all Americans will be affected ...



Rethink Healthcare: Government hospitals must provide quality, affordable medicine
Economic Times (blog)
Delhi government's decision to cancel the licence of Max hospital, Shalimar Bagh, for negligence resulting in the death of a premature newborn – the baby was declared dead by the hospital even though he was alive at the time he was given to his parents ...

and more »


New York Times

What Doctors Should Ignore
New York Times
Those variants are enriched in people of African ancestry. Girish N. Nadkarni, a kidney specialist at Icahn School of Medicine at Mount Sinai in New York City, explained to me that scientists think this may be because those variants protect against the ...



Daily Mail

HEALTH: Nature's medicine for sore joints
Daily Mail
When financier John Carey, then 35, woke up one night in 2002 with a searing pain in the ball of his left foot, the last thing on his mind was gout. 'I'd been training hard the day before – I practise judo and ran marathons – and thought I must have ...



HuffPost

Medicine And Why Net Neutrality Matters
HuffPost
Recently, the library at Einstein, where I work as a medical librarian, experienced a momentary internet outage. In that instant, everything seemed to stop in its tracks. Medical students preparing to take their STEP 1 Board exams couldn't finish their ...

and more »


EurekAlert (press release)

Landmark CAR-T cancer study published in the New England Journal of Medicine
EurekAlert (press release)
IMAGE: This is how CAR-T cell therapy harnesses a patient's immune system to fight cancer. view more. Credit: Loyola Medicine. MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of ...
Loyola Medicine Oncologist Patrick Stiff, MD, Co-Author of Landmark @NEJM CAR-T Study, Offers Measured ...Newswise (press release)

all 5 news articles »

Google News

home | site map | Dr. Thad Thomas
© 2006